# GSK2982772 Study in Subjects With Ulcerative Colitis

> **NCT02903966** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 36 (actual)

## Conditions studied

- Colitis, Ulcerative

## Interventions

- **DRUG:** GSK2982772
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02903966
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-15
- **Primary completion:** 2019-06-17
- **Final completion:** 2019-06-17
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2020-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02903966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02903966, "GSK2982772 Study in Subjects With Ulcerative Colitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02903966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*